What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Archeus Technologies receives FDA clearance for ART-101 to begin prostate cancer therapy trials in 2025 Archeus Technologies wins FDA IND clearance for ART-101, an alpha-emitting radiopharmaceutical therapy targeting PSMA in advanced prostate cancer. byPallavi MadhirajuJune 25, 2025